The portfolio company CMA Microdialysis restructures operations Bure Equity's portfolio company CMA Microdialysis sells its preclinical business and its subsidiary Dilab. CMA Microdialysis continuing operations will be renamed to Dipolyn Medical AB. For more information see enclosed press releases and Dipylon Medicals web page: www.dipylonmedical.com (http://www.dipylonmedical.com) For more information contact: Patrik Tigerschiöld, CEO Tel. +46 8 614 00 20
The portfolio company CMA Microdialysis restructures operations
| Source: Bure Equity AB
Pièces jointes
